Cardiac biomarkers in the prediction of risk in the non-cardiac surgery setting

Anaesthesia

Volumn 69, Issue 5, 2014, Pages 484-493

  Biccard, B M ^a   Devereaux, P J ^b   Rodseth, R N ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; TROPONIN;

ARTICLE; CLINICAL PRACTICE; HEALTH CARE UTILIZATION; HEART SURGERY; HUMAN; INTRAOPERATIVE PERIOD; MEDICAL SOCIETY; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE PERIOD; RISK ASSESSMENT; SURGICAL PATIENT; SURGICAL RISK;

BIOLOGICAL MARKERS; HEART DISEASES; HUMANS; NATRIURETIC PEPTIDE, BRAIN; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RISK ASSESSMENT; SURGICAL PROCEDURES, OPERATIVE; TROPONIN;

EID: 84898991312     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.12635     Document Type: Article

References (47)

1. Devereaux PJ, Chan MT, Alonso-Coello P, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. Journal of the American Medical Association 2012; 307: 2295-304.
2. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372: 139-44.
3. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-9. (Pubitemid 29416229)
4. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2007; 116: 1971-96.
5. Poldermans D, Bax JJ, Boersma E, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). European Heart Journal 2009; 30: 2769-812.
6. Ford MK, Beattie WS, Wijeysundera DN,. Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Annals of Internal Medicine 2010; 152: 26-35.
7. Gupta PK, Gupta H, Sundaram A, et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation 2011; 124: 381-7.
8. Biccard BM, Rodseth RN,. Utility of clinical risk predictors for preoperative cardiovascular risk prediction. British Journal of Anaesthesia 2011; 107: 133-43.
9. Levy M, Heels-Ansdell D, Hiralal R, et al. Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis. Anesthesiology 2011; 114: 796-806.
10. Kheterpal S, O'Reilly M, Englesbe MJ, et al. Preoperative and intraoperative predictors of cardiac adverse events after general, vascular, and urological surgery. Anesthesiology 2009; 110: 58-66.
11. Davenport DL, Ferraris VA, Hosokawa P, Henderson WG, Khuri SF, Mentzer RM Jr,. Multivariable predictors of postoperative cardiac adverse events after general and vascular surgery: results from the patient safety in surgery study. Journal of the American College of Surgeons 2007; 204: 1199-210. (Pubitemid 46819087)
12. Devereaux PJ, Xavier D, Pogue J, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Annals of Internal Medicine 2011; 154: 523-8.
13. Blankenberg S, Zeller T, Saarela O, et al. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 2010; 121: 2388-97.
14. Zethelius B, Berglund L, Sundstrom J, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. New England Journal of Medicine 2008; 358: 2107-16. (Pubitemid 351679597)
15. Rodseth RN, Biccard BM, Le Manach Y, et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic Peptide: a systematic review and individual patient data meta-analysis. Journal of the American College of Cardiology 2014; 63: 170-80.
16. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD,. Third universal definition of myocardial infarction. Journal of the American College of Cardiology 2012; 60: 1581-98.
17. Hlatky MA, Greenland P, Arnett DK, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009; 119: 2408-16.
18. Rodseth RN,. B type natriuretic peptide-a diagnostic breakthrough in peri-operative cardiac risk assessment? Anaesthesia 2009; 64: 165-78.
19. Rodseth RN, Padayachee L, Biccard BM,. A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 2008; 63: 1226-33.
20. Karthikeyan G, Moncur RA, Levine O, et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. Journal of the American College of Cardiology 2009; 54: 1599-606.
21. Melander O, Newton-Cheh C, Almgren P, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. Journal of the American Medical Association 2009; 302: 49-57.
22. Khan SQ, Narayan H, Ng KH, et al. N-terminal pro-B-type natriuretic peptide complements the GRACE risk score in predicting early and late mortality following acute coronary syndrome. Clinical Science (London) 2009; 117: 31-9.
23. Choi JH, Cho DK, Song YB, et al. Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in noncardiac surgery. Heart 2010; 96: 56-62.
24. Rodseth RN, Lurati Buse GA, Bolliger D, et al. The predictive ability of pre-operative B-type natriuretic peptide in vascular patients for major adverse cardiac events an individual patient data meta-analysis. Journal of the American College of Cardiology 2011; 58: 522-9.
25. Biccard BM, Lurati Buse GA, Burkhart C, et al. The influence of clinical risk factors on pre-operative B-type natriuretic peptide risk stratification of vascular surgical patients. Anaesthesia 2012; 67: 55-9.
26. Sarveswaran J, Ikponmwosa A, Asthana S, Spark JI,. Should cardiac troponins be used as a risk stratification tool for patients with chronic critical limb ischaemia? European Journal of Vascular and Endovascular Surgery 2007; 33: 703-7. (Pubitemid 46672806)
27. Gibson SC, Marsh A, Berry C, et al. Should pre-operative troponin be a standard requirement in patients undergoing major lower extremity amputation? European Journal of Vascular and Endovascular Surgery 2006; 31: 637-41. (Pubitemid 43792944)
28. Nagele P, Brown F, Gage BF, et al. High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. American Heart Journal 2013; 166: e1.
29. Weber M, Luchner A, Seeberger M, et al. Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. European Heart Journal 2013; 34: 853-62.
30. Biccard BM, Naidoo P, de Vasconcellos K,. What is the best pre-operative risk stratification tool for major adverse cardiac events following elective vascular surgery? A prospective observational cohort study evaluating pre-operative myocardial ischaemia monitoring and biomarker analysis. Anaesthesia 2012; 67: 389-95.
31. Devereaux PJ, Goldman L, Yusuf S, Gilbert K, Leslie K, Guyatt GH,. Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review. Canadian Medical Association Journal 2005; 173: 779-88. (Pubitemid 41428515)
32. Redfern G, Rodseth RN, Biccard BM,. Outcomes in vascular surgical patients with isolated postoperative troponin leak: a meta-analysis. Anaesthesia 2011; 66: 604-10.
33. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. New England Journal of Medicine 1996; 335: 1342-9. (Pubitemid 26360452)
34. Le Manach Y, Perel A, Coriat P, Godet G, Bertrand M, Riou B,. Early and delayed myocardial infarction after abdominal aortic surgery. Anesthesiology 2005; 102: 885-91. (Pubitemid 40590068)
35. Rodseth RN, Biccard BM, Chu R, et al. Postoperative B-type natriuretic peptide for prediction of major cardiac events in patients undergoing noncardiac surgery: systematic review and individual patient meta-analysis. Anesthesiology 2013; 119: 270-83.
36. Struthers A, Lang C,. The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent 'pancardiac' target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney. European Heart Journal 2007; 28: 1678-82. (Pubitemid 47227107)
37. Suttie S, Mofidi R, McCallum R, et al. Immediately postoperative B-type natriuretic peptide and its predictive value. Annals of Vascular Surgery 2011; 25: 248-55.
38. James SK, Lindahl B, Siegbahn A, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 2003; 108: 275-81. (Pubitemid 36899016)
39. Rodseth RN, Vasconcellos K, Naidoo P, Biccard BM,. Preoperative B-type natriuretic peptide risk stratification: do postoperative indices add value? Southern African Journal of Anaesthesia and Analgesia 2013; 19: 60-5.
40. Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH,. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. Canadian Medical Association Journal 2005; 173: 627-34. (Pubitemid 41345578)
41. Ryan L, Rodseth RN, Biccard BM,. Peri-operative myocardial infarction: time for therapeutic trials. Anaesthesia 2011; 66: 1083-7.
42. van Waes JA, Nathoe HM, de Graaff JC, et al. Myocardial injury after noncardiac surgery and its association with short-term mortality. Circulation 2013; 127: 2264-71.
43. Carlisle J, Swart M,. Mid-term survival after abdominal aortic aneurysm surgery predicted by cardiopulmonary exercise testing. British Journal of Surgery 2007; 94: 966-9. (Pubitemid 47236540)
44. James S, Jhanji S, Smith A, O'Brien G, Fitzgibbon M, Pearse RM,. Comparison of the prognostic accuracy of scoring systems, cardiopulmonary exercise testing, and plasma biomarkers: a single-centre observational pilot study. British Journal of Anaesthesia 2014; 112: 491-7.
45. Biccard BM, Naidoo P,. The role of brain natriuretic peptide in prognostication and reclassification of risk in patients undergoing vascular surgery. Anaesthesia 2011; 66: 379-85.
46. Ioannidis JP, Tzoulaki I,. Minimal and null predictive effects for the most popular blood biomarkers of cardiovascular disease. Circulation Research 2012; 110: 658-62.
47. Gaggin HK, Mohammed AA, Bhardwaj A, et al. Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study. Journal of Cardiac Failure 2012; 18: 626-34.